Advanced search×

Progression of type 2 to type 1 retinopathy of prematurity in the Early Treatment for Retinopathy of Prematurity Study.

Arch Ophthalmol 128(4):461-5 (2010) PMID 20385942

To examine the frequency and timing of progression from type 2 to type 1 retinopathy of prematurity (ROP) in the Early Treatment for Retinopathy of Prematurity Study.

DOI: 10.1001/archophthalmol.2010.34
Version: za2963e q8zad q8zb7 q8zc3 q8zd6 q8ze8 q8zf3 q8zg5

Similar articles you may find interesting…

  1. Final visual acuity results in the early treatment for retinopathy of prematurity study.

    Arch Ophthalmol 128(6):663-71 (2010) PMID 20385926

    These results are particularly important considering that 52% of Type 2 high-risk prethreshold eyes underwent regression of ROP without requiring treatment. Trial Registration clinicaltrials.gov Identifier: NCT00027222....
  2. Coats disease and exudative retinopathy.

    Int Ophthalmol Clin 51(1):93-112 (2011) PMID 21139479

  3. Comparison of primary position measurements and abduction deficit between type 1 Duane syndrome and sixth cranial nerve palsy.

    J Neuroophthalmol 31(2):117-20 (2011) PMID 21343829

    : Mean abduction deficit was -3.5 ± 0.1 for DRS-I and -2.6 ± 0.2 for 6NP (P = 0.0004). Mean esotropia at near was 8.4 ± 1.1 prism diopters (PD) for DRS-I and 27.2 ± 2.4 PD for 6NP (P < 0.0001). Mean esotropia at distance was 10.3 ± 1.3 PD for DRS-I and 36.4 ± 2.4 PD for 6NP (P < 0.0001). The me...